The effect of thick burdock extracts on development of model hyperplasia of the prostate gland in rats
DOI:
https://doi.org/10.24959/cphj.17.1433Keywords:
thick burdock extracts, benign prostatic hyperplasia, prostatoprotective action, anti-inflammatory activity, antioxidant actionAbstract
Benign prostatic hyperplasia (BPHP) is one of the most common diseases in middle-aged and elderly men. In this regard, the search and study of new effective and safe medicines with the prostatoprotective effect is important and topical. For today, the nomenclature of domestic protostatotectors of the plant origin is limited.
Aim. To study experimentally the protoprotective properties of thick extracts of roots and leaves of common burdock on the model of sulpiride-induced prostatic hyperplasia in rats.
Materials and methods. The BPHP model reproduced the intraperitoneal administration of sulpiride to male rats in the dose of 40 mg/kg for 30 days. Thick burdock extracts in the dose of 75 mg/kg and the reference drug Prostaplant Forte in the dose of 35 mg/kg were administered intraperitoneally in the therapeutic regimen from day 31 to day 52 of the study.
Results. It has been proven that thick extracts of roots and leaves of burdock on the model of sulpiride-induced benign prostatic hyperplasia in rats reduce development of inflammatory processes, inhibit the processes of LPO, normalize the antioxidant / prooxidant balance in the animal’s body. Under the influence of these extracts the level of androgenic saturation of the body and the testosterone/estradiol ratio increase, indicating a positive effect of drugs on spermatogenesis. Thick extracts of burdock roots and leaves reduce the level of estradiol and dihydrotestosterone in the blood serum of the experimental animals, and it impedes development of proliferative processes in the prostate and inhibits development of the disease.
Conclusions. By the intensity of the prostatoprotective action thick extracts of roots and leaves of common burdock are not inferior to the reference drug Prostaplant Forte.
References
Kuzmenko, V. V., Kochetov, M. V., Semenov, B. V. (2008). Dobrokachestvennaia giperplaziia predstatelnoi zhelezy. Voronezh,
Zaichenkо, H. V., Ryzhenko, І. М., Chystiakov, О. H. et al. (2008). Provizor, 16, 39–46.
Drogovoz Mokhamad, A. (2013). Eksperymentalne vyvchennia protyzapalnykh vlastyvostei hustykh ekstraktiv lopukha velykoho.,
S. M., Bukhtiarova, T. A., Rossikhin, V. V. et al. (2005). Prostatoprotektory. Kharkiv: Pleiada, 184.
Mokhamad, A. (2013). Eksperymentalne vyvchennia protyzapalnykh vlastyvostei hustykh ekstraktiv lopukha velykoho.
Kharkiv, 167.
Chan, Y.–S., Cheng, L.–N., Wu, J.–H., Chan, E., Kwan, Y.–W., Lee, S. M.–Y., Chan, S.–W. (2010). A review of the pharmacological
effects of Arctium lappa (burdock). Inflammopharmacology, 19 (5), 245–254. doi: 10.1007/s10787–010–0062–4
Predes, F. S., Ruiz, A. L., Carvalho, J. E., Foglio, M. A., Dolder, H. (2011). Antioxidative and in vitro antiproliferative activity of
Arctium lappa root extracts. BMC Complementary and Alternative Medicine, 11 (1). doi: 10.1186/1472–6882–11–25
Andriianenkov, О. V., Zaichenkо, H. V., Tartynska, H. S. (2012). Visnyk farmatsii – News or Pharmacy, 3 (71), 79–82.
Catherine, S., Vera, U. (2016). Investigation of antioxidant and anti–inflammatory properties of burdock thick extracts on
the model of benign prostatic hyperplasia (BPHP) in rats. Journal of Molecular Pathophysiology, 5 (3), 55. doi: 10.5455/
jmp.20160601012744
Karakovska, N. Ye. (2014). Eksperymentalne vyvchennia prostatoprotektornykh vlastyvostei hustykh ekstraktiv lopukha velykoho.
Kharkiv, 169.
Arutiunian, A. V., Dubina, E. E. (2000). Metody otcenki svobodno–radikalnogo okisleniia i antioksidantnoi sistemy organizma.
St. Petersburg: Foliant, 104.
Kamyshnikov, B. S. (2000). Spravochnik po kliniko–biokhimicheskoi laboratornoi diagnostike. Minsk: Belarus, 495.
Tiktinskii, O. L., Kalinina, S. N., Mikhailichenko, V. V. (2010). Andrologiia. Moscow: MedInformAgentstvo, 576.
Narayan, P. (2000). Benign prostatic hyperplasia. London: Livingstone, 402.
Downloads
Published
Issue
Section
License
Copyright (c) 2017 National University of Pharmacy

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).